Content Status

Type

Linked Node

H5Content
Content

Clinical monitoring is one of the major components of the follow-up monitoring of Drug Resistant-TB (DR-TB) patients. 

 

The objective of regular clinical monitoring of patients is to ensure that the patient is adhering to treatment, progressing well and adverse effects are recognized early. 

 

Patients on any DR-TB regimen should be seen by a doctor trained in The National TB Elimination Programme Programmatic Management of Drug-resistant Tuberculosis (NTEP PMDT) guidelines for clinical evaluation on a monthly basis. Preferably, a day may be fixed for the monthly follow-up. 

 

During the follow-up visits the patient should be assessed for:

  • Clinical, bacteriological and radiological response to DR-TB treatment
  • Weight of the DR-TB patient
  • Possible adverse events due to DR-TB treatment
  • Other relevant investigations may be done as and when clinically indicated

 

Some patients may need to be hospitalized during the treatment for medical/ psychosocial reasons. ​The patient should be encouraged to continue the anti-TB treatment.

 

Specialist consultation needs to be sought based on the clinical requirements, for example, Psychiatrist, Ear Nose Throat (ENT) specialist, Paediatrician, Cardiologist, Gynaecologist, etc.

 

Resources

 

 

Kindly provide your valuable feedback on the page to the link provided HERE

Page Tags

Content Creator

Reviewer